Tippett H L, Dodgson L K, Hunt N P, Lewis M P
Division of Biomaterials and Tissue Engineering and Orthodontic Unit, UCL Eastman Dental Institute, London, UK.
Eur J Orthod. 2008 Apr;30(2):217-25. doi: 10.1093/ejo/cjm105. Epub 2008 Feb 8.
Environmental remodelling of the craniofacial musculature is obligatory for successful outcomes following interventions such as functional appliance therapy or orthognathic surgery. Genetically driven remodelling of the craniofacial musculature is also seen in individuals with altered facial form. The processes that are involved in the remodelling of intramuscular connective tissue need to be activated in such situations. Such processes require activity of matrix metalloproteinases (MMPs) and the tissue inhibitors of matrix metalloproteinases (TIMPs), which are responsible for extracellular matrix (ECM) turnover. The aim of this study was, therefore, to establish the expression of MMP-2 and MMP-9 and their inhibitors, TIMP-1 and TIMP-2, in the masseter muscle of humans with both normal and increased vertical facial form and to assess whether this expression had any value as a predictor of facial form. Biopsies were taken from 20 subjects (10 with vertical facial deformity and 10 with normal vertical facial form to act as a control group). The sample group consisted of 15 females and 5 males and the average age of the donors +/- standard deviation (SD) was 26.04 +/- 6.16 years (range: 17.67-31.25 years). Biopsy samples were then subjected to zymography and reverse zymography to assess MMP and TIMP expression, respectively. Lateral skull cephalograms were analysed for each subject using Spearman's rho correlation coefficients and Mann-Whitney U-tests. TIMP-1 activity was consistently expressed in human masseter muscle. MMP-2, MMP-9, and TIMP-2 activity, when detected, was at a low level. These data indicate that in most individuals, an excess of TIMP-1, compared with MMP-2 and MMP-9, limits ECM turnover in human masseter muscle. There was a demonstrable variation in proteinase expression between different individuals. These preliminary findings, however, do not confirm that indices of ECM turnover are a reflection of an individual's vertical facial form.
对于功能矫治器治疗或正颌外科手术等干预措施而言,颅面肌肉组织的环境重塑是取得成功治疗效果的必要条件。在面部形态改变的个体中也可观察到由基因驱动的颅面肌肉组织重塑。在这些情况下,需要激活参与肌内结缔组织重塑的过程。这些过程需要基质金属蛋白酶(MMPs)和基质金属蛋白酶组织抑制剂(TIMPs)的活性,它们负责细胞外基质(ECM)的更新。因此,本研究的目的是确定MMP - 2和MMP - 9及其抑制剂TIMP - 1和TIMP - 2在垂直面部形态正常和增加的人类咬肌中的表达,并评估这种表达是否具有作为面部形态预测指标的价值。从20名受试者身上获取活检样本(10名患有垂直面部畸形,10名具有正常垂直面部形态作为对照组)。样本组由15名女性和5名男性组成,供体的平均年龄±标准差(SD)为26.04±6.16岁(范围:17.67 - 31.25岁)。然后对活检样本分别进行酶谱分析和反向酶谱分析,以评估MMP和TIMP的表达。使用Spearman秩相关系数和Mann - Whitney U检验对每个受试者的头颅侧位X线片进行分析。TIMP - 1活性在人类咬肌中持续表达。MMP - 2、MMP - 9和TIMP - 2活性在检测到时处于低水平。这些数据表明,在大多数个体中,与MMP - 2和MMP - 9相比,TIMP - 1过量限制了人类咬肌中ECM的更新。不同个体之间蛋白酶表达存在明显差异。然而,这些初步发现并未证实ECM更新指标反映了个体的垂直面部形态。